For condition: Psoriasis
Research Trial for Moderate-to-Severe Plaque Psoriasis (52-68 Weeks)
Study Summary
Who Can Participate?
Adults 18 to 70 years of age with moderate-to-severe plaque psoriasis may be eligible participate.
Inclusion Criteria
- Diagnosis of moderate-to-severe plaque psoriasis for at least 6 months
- Stable plaque psoriasis affecting 10% or more of the body (i.e. about the size of 10 handprints)
- Don’t have any other skin disease which may interfere with assessment of plaque psoriasis
Participant Information
- Participate and receive study treatment at no cost
- Regular visits with study doctors who specialize in treating plaque psoriasis
- Will receive either an investigative injection treatment (study drug) or a placebo
- Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
- Participation will last about 52-68 weeks and involve about 13-18 visits to the study research site.
For more information about this trial, please visit ClinicalTrials.gov
